Cabometyx 40 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DX25F6ADE
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $65,933
Award facts
- Contract value 100% obligated
- $65,932.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) Medical Supply Chain, through its Indefinite Delivery Contract (IDC) SPE2DB program with DMS Pharmaceutical Group Inc., awarded a firm fixed-price delivery order on August 14, 2025, for Cabometyx 40 mg tablets in quantities of 30. This delivery order, valued at approximately $65,933, represents a continuation of the agency's pharmaceutical supply chain operations supporting Department of Defense healthcare facilities. The award carries no set-aside designation and reflects the DLA's standard procurement practices for branded pharmaceutical products necessary to support military health system operations nationwide.
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, holds the underlying $500 million IDC with the DLA valid through November 2026. The company specializes in distributing branded and generic prescription drugs, biologics, and medical consumables to federal healthcare systems, with a proven track record of delivering specialized pharmaceutical products including oncology treatments and other critical medications. The Park Ridge location serves as the place of performance for this delivery order, with the completion date scheduled for August 15, 2025, ensuring timely supply of this essential cancer treatment medication to support the military healthcare enterprise.
Quick answers
Who was awarded contract SPE2DX25F6ADE?
SPE2DX25F6ADE was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on August 14, 2025.
How much is contract SPE2DX25F6ADE worth?
The government has obligated $65,933 on SPE2DX25F6ADE.
Is contract SPE2DX25F6ADE an order under another contract?
Yes. SPE2DX25F6ADE is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6ADE competed?
The extent of competition for SPE2DX25F6ADE was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award